I am a breastfeeding mother and i want to know if it is safe to use N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate? Is N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate safe for nursing mother and child? Does N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate extracts into breast milk? Does N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate has any long term or short term side effects on infants? Can N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate influence milk supply or can N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate decrease milk supply in lactating mothers?

- DrLact safety Score for N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using N,N-Diethyl-4-methyl-1-piperazinecarboxamide dihydrogen citrate We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Used in the treatment of filaria, loa, mansonella and toxocara infection. Not longer recommended for onchocerciasis. Dosage for children is available. Periodic treatment strategies for entire populations have been undertaken (not recommended for newborns). Diethylcarbamazine enriched salt has been used. Check-up for untoward effects related to the drug itself which are usually mild and parasite killing dependent. Not commercially available in Spain.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.